Related by context. Frequent words. (Click for all words.) 72 Blood Thinner 72 Prostate Cancer Patients 72 Patients Undergoing 71 Reduces Risk 71 Cholesterol Drug 71 Blood Clots 71 Drug Resistant 71 Advanced Prostate Cancer 71 Increases Risk 71 Elderly Patients 71 Chronic Hepatitis C 70 Clinical Trial Results 70 Well Tolerated 70 Drug Candidate 69 Breast Cancer Patients 69 Cardiovascular Events 69 Phase III Clinical Trial 69 Heart Failure Patients 69 Hormone Therapy 68 Cervical Cancer Vaccine 68 Patients Treated 68 Diabetic Patients 68 Phase III Trial 68 Monotherapy 68 Dialysis Patients 68 Gum Disease 67 Breast Cancer Treatment 67 Smallpox Vaccine 67 Benign Prostatic Hyperplasia 67 Postmenopausal Women 67 Increased Risk 67 Venous Thromboembolism 67 Overactive Bladder 67 Completes Enrollment 67 Newly Diagnosed 67 Ear Infections 67 Patient Enrollment 67 Preclinical Data 67 FDA Warns 66 Cancer Treatments 66 Generic Version 66 Significantly Reduces 66 Reduce Risk 66 Bladder Cancer 66 Low Dose 66 Cancer Cells 66 Helps Prevent 66 Bypass Surgery 66 Holds Promise 66 Shows Promise 66 Treatable 65 Extended Release 65 Heart Attacks 65 Study Demonstrates 65 Allergic Rhinitis 65 FDA Clears 65 Autoimmune Diseases 65 Life Threatening 65 Acute Coronary Syndromes 65 Diet Pill 65 Prostate Cancer Treatment 65 Regimens 65 Randomized Controlled Trial 64 Gastric Cancer 64 Pulmonary Arterial Hypertension 64 Metastatic Colorectal Cancer 64 Metastatic Melanoma 64 Insulin Resistance 64 Presents Positive 64 Blood Vessels 64 Meta Analysis 64 Brain Cells 64 Blood Clot 63 Urinary Incontinence 63 Prophylaxis 63 Inhibits 63 Be Treated 63 Radiation Exposure 63 Pivotal Phase 63 Acid Reflux 63 Hepatitis C Virus 63 Quitting Smoking 63 Acute Myocardial Infarction 63 Thyroid Cancer 63 Healthbeat 63 Flu Vaccines 63 Brain Tumors 63 FDA Approves 63 Malaria Vaccine 63 Cancer Diagnosis 63 Combination Therapy 62 Belly Fat 62 Autoimmune Disease 62 Kidney Stones 62 Esophageal Cancer 62 Protect Against 62 Pivotal Phase III 62 Protects Against 62 FDA Accepts 62 Pivotal Trial 62 Receives FDA Clearance